+    Slows the aging process
+    Improves GI barrier function
+    Enhances physical and mental resilience under stress
+    Improves immunity and hastens clearance of infections
+    Powerful blend of oral immune­modulating dipeptides.
+    Restores immunity in inflammatory disease.

Thymogen with immune peptide A2 (IPA2) is a synergistic blend of immune-modulating, bioregulator dipeptides. This combination of peptides Glu-Tryp (thymogen) and Lys-Glu (IPA2) was designed to replace, even outperform, the peptide thymosin alpha-1. Shown in numerous clinical trials and in the use of metabolic testing, the components of thymogen and IPA2 are more potent and beneficial than thymosin alpha-1, including having more potent antimicrobial effects and positive influence on morbidity, mortality, and multi-system deterioration seen with aging. 
Thymogen with IPA2 has been shown to be especially effective in support of the immune system, benefitting the normalization of absolute counts of T and B lymphocytes, enhancing thymus activity, and reducing hTGFb, increasing white blood cell count and activity, among other benefits. Both components of this combination peptide improve immunity and homeostasis associated with infections and hasten the clearance of infections. 
Individually, thymogen is associated with improvements of numerous conditions including cancer, aging, stress-related immunosuppression, inflammatory disease, chronic infection, uterine diseases, tissue repair disorders, and autoimmune disease. I PA2 has been shown to improve symptoms of aging and reduce cell senescence, optimize GI function, optimize coagulation, and is associated with a significant reduction in the incidence of cancer.